CASI Pharma (CASI) Reports Q3 Loss of $0.05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to CASI Pharma (CASI) Reports Q3 Loss of $0.05

CASI Pharmaceuticals Reports Third Quarter 2015 Financial Results

November 13, 2015 7:00 AM EST

ROCKVILLE, Md., Nov. 13, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, today reported financial results for the three and nine months ended September 30, 2015.

CASI reported a net loss for the third quarter of 2015 of ($1.6 million), or ($0.05) per share.  This compares with a net loss of ($21.5 million), or... More